Literature DB >> 17645445

Testosterone therapy and obstructive sleep apnea: is there a real connection?

Han M Hanafy1.   

Abstract

INTRODUCTION: With the recent increased recognition and treatment of hypogonadism in men, a caution has been given that testosterone replacement therapy (TRT) may cause or aggravate obstructive sleep apnea syndrome (OSA). AIM: To evaluate the scientific data behind the cautionary statements about TRT and OSA. MAIN OUTCOME MEASURES: Methodology and criteria for such studies and evaluation of documents and results based on methodology, duration, and outcome of treatment.
METHODS: A review of the literature on the subject of TRT and OSA was performed. The possible mechanisms of action of TRT, on breathing and respiration during sleep were explored. RESULT: Historically, the first such caution came in 1978. Since then, a few similar incidence reports have been cited. The total number of patients in such reports was very small, very disproportional to the millions of patients treated with TRT. Also, there was a lack of consistent findings connecting TRT to OSA. In addition, different results may occur with physiologic replacement vs. supraphysiologic doses in regard to breathing and OSA. The studies showing the effect of TRT on OSA and breathing were all case studies with small numbers of subjects and showed little effect of TRT on OSA in the majority of case reports. Only one study using supraphysiologic doses was a double-blind, placebo-controlled study, which showed a development of OSA in healthy pooled subjects. The other reports were case studies with limited numbers of subjects, suggesting an inconsistent effect of supraphysiologic TRT on OSA and breathing.
CONCLUSION: Cautionary statements about TRT in OSA appear frequently in the TRT literature and guidelines, despite lack of convincing evidence that TRT causes and/or aggravates OSA. Also, there is a lack of consistency in the findings connecting TRT to OSA. It is evident that the link between TRT and OSA is weak, based on methodological issues in many of the studies, and most studies involved small numbers of men. Further studies in this area are needed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17645445     DOI: 10.1111/j.1743-6109.2007.00553.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  18 in total

1.  Testosterone restores respiratory long term facilitation in old male rats by an aromatase-dependent mechanism.

Authors:  N R Nelson; I M Bird; M Behan
Journal:  J Physiol       Date:  2010-11-15       Impact factor: 5.182

Review 2.  The evaluation and management of testosterone deficiency: the new frontier in urology and men's health.

Authors:  William P Conners; Abraham Morgentaler
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

Review 3.  Sex steroidal hormones and respiratory control.

Authors:  Mary Behan; Julie M Wenninger
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

4.  An update on male hypogonadism therapy.

Authors:  Prasanth Surampudi; Ronald S Swerdloff; Christina Wang
Journal:  Expert Opin Pharmacother       Date:  2014-04-23       Impact factor: 3.889

5.  Bone loss in obesity and obstructive sleep apnea: a review of literature.

Authors:  Marlene Chakhtoura; Mona Nasrallah; Hassan Chami
Journal:  J Clin Sleep Med       Date:  2015-04-15       Impact factor: 4.062

Review 6.  Sex differences in sleep apnea and comorbid neurodegenerative diseases.

Authors:  Brina Snyder; Rebecca L Cunningham
Journal:  Steroids       Date:  2017-12-16       Impact factor: 2.668

7.  On Not Knowing What We Don't Know to Knowing What We Don't Know: Obstructive Sleep Apnea in the Transgender Community.

Authors:  David C Earl; Lee K Brown
Journal:  J Clin Sleep Med       Date:  2019-10-15       Impact factor: 4.062

8.  The Effects of Transgender Hormone Therapy on Sleep and Breathing: A Case Series.

Authors:  Brian D Robertson; Brian S Lerner; Jacob F Collen; Patrick R Smith
Journal:  J Clin Sleep Med       Date:  2019-10-15       Impact factor: 4.062

Review 9.  Male late-onset hypogonadism: pathogenesis, diagnosis and treatment.

Authors:  Ilpo Huhtaniemi; Gianni Forti
Journal:  Nat Rev Urol       Date:  2011-04-19       Impact factor: 14.432

10.  Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.

Authors:  C Wang; E Nieschlag; R Swerdloff; H M Behre; W J Hellstrom; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; A Morales; J E Morley; C Schulman; I M Thompson; W Weidner; F C W Wu
Journal:  Eur J Endocrinol       Date:  2008-11       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.